Corrinne Burns

Royal Pharmaceutical Society Correspondent

Corrinne Burns is Royal Pharmaceutical Society Correspondent at The Pharmaceutical Journal.

ADHD medication associated with reduced risk of adverse life events

In nearly 150,000 patients with ADHD, first incidences of suicidal behaviour, substance misuse, transport accidents and criminal convictions were lower in those who had started drug treatment within three months of diagnosis.…

Almost 400,000 people have used NHS App prescription tracker

Around 1,650 community pharmacies, including every Boots pharmacy in England, are now offering the service, say NHS England.…

Royal Pharmaceutical Society Assembly meeting: 16 July 2025

An overview of the latest meeting of the Royal Pharmaceutical Society Assembly.…

Only one in ten people report side effects, Healthcare Improvement Scotland warns

Healthcare Improvement Scotland is calling for greater awareness of the Yellow Card scheme, as too few patients report medication side effects.…

Health security agency warns over Lyme disease despite fall in cases

A report published by the UK Health Security Agency suggests that the drop in Lyme disease cases may be an “underestimate of the true burden” of cases in England.…

NICE recommends ongoing support when coming off weight-loss medications

An updated quality standard has highlighted the importance of advice in order to improve health and wellbeing as patients are taken off weight-loss drugs.…

Some women stop breastfeeding following ‘overly cautious’ medication advice

Authors of a review on how medication use affects breastfeeding found that many cases of medication-related breastfeeding discontinuation may be avoidable.…

NHS data show drop in prescribing of dependency-forming medicines

The medicines featured in the NHS Business Services Authority report include gabapentinoids, opioids, benzodiazepines and Z-drugs.…

TB medicines shortage to last until end of 2025

A national patient safety alert has asked hospital procurement teams to review current stocks and work towards accessing licensed and unlicensed supplies, where available.…

MHRA ‘shares concerns’ over failure to meet epilepsy drug prescribing target

Exclusive: Alison Cave, chief safety officer at the MHRA, has echoed concerns about persistent sodium valproate prescribing raised by the Independent Fetal Anti-Convulsant Trust.…